Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial
2017 ◽
Vol 19
(8)
◽
pp. 1127-1134
◽
Keyword(s):
2018 ◽
Vol 9
(5)
◽
pp. 457-461
◽
2018 ◽
Vol 10
(1)
◽
pp. 84-93
◽
2013 ◽
Vol 37
(4)
◽
pp. 435-439
◽
Keyword(s):
2009 ◽
Vol 19
(2)
◽
pp. 237-264
◽
Keyword(s):
2010 ◽
Vol 20
(1)
◽
pp. 22-25
◽
Keyword(s):
2013 ◽
Vol 15
(11)
◽
pp. 1013-1021
◽
2008 ◽
Vol 153
(S1)
◽
pp. S76-S81
◽
Keyword(s):
Keyword(s):